Seven ai/ml for life sciences companies identified as innovators in new clarivate companies to watch report

Rapid acceleration in ip creation and scientific knowledge drives growing acceptance of ai and ml in drug discovery and development united states and mainland china continue to lead innovation and remain at the forefront of ai technology advancement for drug discovery london , sept. 27, 2023 /prnewswire/ -- clarivate plc (nyse:clvt), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its annual companies to watch report.
CLVT Ratings Summary
CLVT Quant Ranking